tocophersolan has been researched along with Candidiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Alzahrani, AH; Badr-Eldin, SM; Elfaky, MA; Fahmy, UA; Hawsawi, SA; Kotta, S; Qassim, M; Sirwi, A; Yaseen, AY | 1 |
| Chantasart, D; Mingkwan, T; Suksiriworapong, J | 1 |
| Cai, S; Hou, W; Liu, F; Sun, L; Tang, X; Zhang, R; Zhu, H | 1 |
3 other study(ies) available for tocophersolan and Candidiasis
| Article | Year |
|---|---|
Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Mice; Micelles; Phospholipids; Polyethylene Glycols | 2022 |
Enhanced transmucosal delivery of itraconazole by thiolated d-ɑ-tocopheryl poly(ethylene glycol) 1000 succinate micelles for the treatment of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Humans; Itraconazole; Micelles; Mouth Mucosa; Nanoparticles; Polymers; Vitamin E | 2017 |
Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Carriers; Ethylene Glycols; Kidney; Liver; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Vitamin E | 2014 |